Malignancy

  1. cancer defined
    uncontrolled and unregulated growth of cells
  2. 2 dysfunctions of cancer
    • deffective cellular proliferation(growth)
    • defective cellular differentiation
  3. cellular prolif in normal cells
    • growth begins at stem cell
    • equilibrium is maintained
    • respect boundries and teritories
  4. cellular prolif cancer cells
    • no respect for boundaries
    • invasion
    • grows ontop or between other cells
    • indiscriminate and continuous
  5. class of cells
    • asymmetry
    • border
    • colur
    • diameter
  6. cancer involves the malfunction of genes that control____
    differenciation and proliferation
  7. normal genes affected by mutation
    • protooncogenes
    • tumor suppresor genes
  8. protooncogenes
    • promote growth
    • normal genes
  9. oncogenes
    • tumor inducing genes
    • can turn cells from normal to malignant
  10. 3 stages of cancer development
    • initiation
    • promotion
    • progression
  11. initiation
    occurs due to mutation in genes
  12. initiation can be caused by
    • virus
    • hormones
    • radiation
    • chemicals
  13. initiation description
    • not a tumor cell yet
    • still reversable
    • inherited or aquired
  14. promotion
    • increase in altered cell population
    • still reversable
  15. promoting factors
    • smoking alcohol
    • dietary fat
    • obesity
    • prevention is key
  16. latent period
    • (initiation and promotion)
    • the time between the initial genetic mutation and the clinical evidence of cancer
  17. smallest detectable cancer on mri
    1/2 cm
  18. progression
    • needs own blood supply
    • rapid growth
    • matastisis
    • tumor angiogenisis
    • invading
    • traveling
    • penetrate lymph and vascular vessles
  19. tumor angiogenisis
    formation of blood vessles within the tumor itself
  20. metastisis
    • -active
    • -must endure turbulent flow of blood
    • -endure hosts immune system
  21. role of immune system
    • -respond to TAA(tumor assc antigens)
    • -immunologic survalience
  22. immunologic surveilance
    immune systems response to antigens of malignant cells
  23. immune cells
    • cytotoxic t cells
    • natural killer cells
    • macrophages
    • b cells
  24. cytoxic t cells
    • -resist tumors
    • produce cytokines which stimulate t cell, nk, b cell and macrophage
  25. NK cells
    directly lyse tumor cells
  26. monophages
    hemmoragic lytic of tumor cells
  27. b cells
    produce anitbodies
  28. immunologic escape
    cancer cells evade the immune system
  29. oncofetal antigens
    • tumor antigens
    • tumor markers
    • found on surface and inside cancer cells and fetal cells
  30. tumor classification
    • -anatomic site
    • -histology(grading)
    • -extent of diseas(staging)
  31. anatomic site classification
    • -epithelia tissue(carcinoma)
    • -Connective tissue(sarcoma)
    • -Hematopoietic(leukemia)
    • -nervous tissue(meningeal)
  32. histologic class
    • -evaluate appearance of cells and degree of differentiation
    • -5 grades
    • -higher the grade the the worse
    • -degree to which cells resemble tissue of organ
  33. extent of disease
    • -clinical staging 
    • -TNM classification
  34. clinical staging
    • -anatomical extent rather than cell appearance
    • -5 stages
  35. TNM classification
    anatomical extent of disease involvement based on tumor size, spread, and metastis to organs
  36. CAUTION
    • C-change in bowl/bladder
    • A- a wound that wont heal
    • U- unusal bleeding
    • T- thinking you have a lump
    • I- indigestion, swallowing
    • O- obvious change in wart/mole
    • N- aging cough or horse voice
  37. biopsy
    removal of tissue sample for pathologic analysis
  38. types of biopsy
    • percuetaneous
    • endoscopic
    • surgical
  39. ___ is used in conjunction with biopsy
    radiographics
  40. control
    • -for cancers that cant be completely eradicated but are responsive to therapy
    • -multiple myloma
    • -certain lung cancers
    • -chronic lyphocytic leukemia
  41. palliation
    • -managing symptoms
    • -treatment goal
    • -radiation or chemo
  42. goals of cure, control and palliate
    • surgery
    • radiation
    • chemo
    • biologic and target therapy
  43. factors used to determine the response of cancer cells to chemo
    • -mitotic rate
    • -size of tumor
    • -age of tumor
    • -location of tumor
    • -presense of resistant tumor
  44. classification of chemo agents
    • -according to cell cycle
    • 1. specif
    • 2. nonspecific
  45. cell cycle phase non specific
    acts at any point in the cell cycle
  46. cell cycle phase specific
    interrupts cell division at specific points
  47. chemical structure classifications
    • chemical fam with the most common side effects
    • alkylating agents
    • nitroureas
    • platinum drugs
    • antimetabolites
    • -antitumor AB
    • -mitotic inhibitors
    • topoisomes
  48. extravsion
    infiltration of drugs into tissue surrounding infusion site causing local tissue damange
  49. radiation therapy
    • used to treat local or regional disease
    • aim is to destroy malignant cells
  50. radiosensitivity

    normal and cancer:
    nondividing:
    Exception:
    Tumor:
    Normal:
    • -affected by radiation
    • -"slowly dividing" less radiosensitive
    • --small lymph and salivary are non dividing but very radiosensitive
    • -not able to repair dna damage
    • -are able to repair dna damage
  51. teletherapy
    • -external radiation therapy
    • -most widely used
    • -larger areas o be treated
    • -5 days a week over 2-7 weeks
  52. brachytherapy
    • -internal radiation
    • -directly on or near tumor
    • -alone or w/ other therapies
    • -sealed seeds and ribbons
  53. radio pharmaceutical therapy
    oral
  54. brachytherapy safety
    • ALARA
    • time
    • distance
    • shielding
  55. myelosuppresion
    • -most common effects of chemo and radiation
    • -RBC, WBC, Platelets
    • -decrease in blood count
    • -monitor CBC
  56. Nadir
    • -lowest blood cell count
    • -7-10 days post chemo
    • -onset depends on drug regime and host
    • -neutrophil, platelet and RBC
  57. pulmonary reaction
    • cough
    • sob
    • pneumonitis
    • pulmonary fibrosis
  58. cardio reactions
    • ecg changes
    • lv dysfunction
    • heart failure
    • cardiac ischemia
  59. biologic immune therapy
    • -antibodies bind to and target antigens
    • -antibodie is specific to an antigen(key for target therapy)
  60. target therapy
    • --more specific for molecular targets than chemo
    • -do less damage to normal cells than chemo
  61. immune and target therapies
    • -cytokines
    • -kinase inhibitors
    • -vaccines
    • -monoclonal antibodies
    • -angiogenesis inhibitors
    • -proteasome inhibitors
    • -programmed death receptor blockers
    • -human epidural growth
  62. biological/ target therapies side effects
    • flu like s/s
    • cap leak and pulm edema
    • bone marrow depression
    • fatigue
  63. hormone therapy
    • cortigo steroids
    • estrogen
    • aromatase
    • androgen
  64. hematopoietic growth factors
    • CSF
    • ESA
  65. hematopoietic growth factors

    CSF
    • -glycoproteins
    • -stim production, maturation, regulation and activation of hema cells
    • -specific
  66. hematopoietic growth factors

    ESA
    • -only for anemia caused by chemo
    • -avoided in curative situations
    • -monitor hemoglobin
  67. hematopoietic stem cell transplant
    • -BMT and PSCT
    • -safe in high doses
    • -tumors have resisted standard dose of chemo/radiation
    • -long term/delayed complications
    • -eradicate tumor cells and marrow to make way for transplant
  68. types of stem cell transplant
    • allogenic
    • syngeneic
    • autologous
  69. allogenic
    • grafted from donor
    • HLA
  70. synergeneic
    • type of allogenic
    • identical twins
  71. autologus
    receive their own stem cells after myeoblative chemo
  72. harvest
    • collect bone marrow
    • PIV blood draw and separate marrow
  73. complications of stem cell transplant
    • -bacterial, fungal, viral
    • -prophylactic measures are taken
  74. SVC syndrom
    -facial periorbital edema, head neck chest vein distention due to compression of SVC
  75. oncologic emergencies

    obstructive
    • -tumor related emergencies
    • SVC syndrome, spinal cord compression, third spacing
  76. spinal cord compression
    neuro s/s caused by compression of spinal cord
  77. third spacing
    s/s of shock due to fluid shifts from vascular to interstitial space
  78. metabolic emergencies
    • caused by ectopic hormones produced by cancer cells
    • SIADH
    • Hypercalcemia
    • tumor lysis syndrom
  79. SIADH
    -due to abnormal production of ADH which leads to H2O retention and hyponatremia
  80. Hypercalcemia
    from bone mets or increased PTH release
  81. tumor lysis syndrom
    • -massive cellular destruction
    • -hyperuricemia, hyperphosphatemia, hyperkalemia, hypocalcemia
    • -goal is to prevent renal failure and sever electrolyte imbalance
  82. infiltrative emergencies
    • when malignant tumors infiltrate major organs
    • -cardiac tamponade
    • -carotid artery rupture
  83. cardiac tamponade
    fluid accumulation in the pericardium
  84. carotid artery rupture
    due to invasion of artery by tumor
Author
ChelseaL
ID
342303
Card Set
Malignancy
Description
Malignancy
Updated